Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
INFECTIVE ENDOCARDITIS (IE) is a deadly disease. Despite improvement in early diagnosis and management, IE remains associated with high mortality and severe complications. After the 2009 ESC guidelines these updated guidelines on IE takes account of new publications - including the first randomised study of surgical treatment and the important improvement of imaging (especially nuclear imaging).
Access the Guidelines here
The guidelines focus on prophylaxis, a new concept of ‘reference centre and endocarditis team’, the role of TEE and TOE, the new Duke criteria and a very detailed update on antibiotic treatment. They provide the clinician with an evidence-based scoring system based on a classification of the strength of recommendations and the level of evidence. And as a new feature after each section there is a concise summary of what aspects have been reviewed.
As in the previous guidelines on IE, prophylaxis is considered only for the highest risk patients when a highrisk procedure is performed. At the same time non-specific prevention measures are advised in high-risk and intermediate risk patients.
After long discussions among the task force, a very practical algorithm has been proposed for the patient with known or suspected for IE.
One of the most important parts of the new guidelines is the concept of a reference centre and endocarditis team. Thus, the guidelines state: ‘Patients should be evaluated and managed at an early stage in a reference centre, with immediate surgical facilities and the presence of a multidisciplinary team, the ‘Endocarditis Team’. This should include a cardiologist an infectious disease specialist, a microbiologist, imaging specialist, a cardiac surgeon, and, if needed, a specialist in CAD.
The cornerstone of diagnostic criteria for IE remains the modified Duke criteria, which are categorised in ‘Definite’, ‘Possible’ and ‘Rejected’ IE. The task force proposed the addition of a further two major imaging criteria: the detection of paravalvular lesions by cardiac CT and ‘an abnormal activity around the site of a prosthetic valve detected by 18F-FDG PET/CT or radiolabelled leucocyte SPECT/ CT’, with the detection of embolic events/vascular phenomena detected by imaging alone a minor criteria. A clear catalogue of anatomical and echocardiographic definitions of what constitutes a vegetation, abscess, pseudoaneurysm, perforation, fistula, valve aneurysm, and dehiscence of a prosthetic valve has been agreed to facilitate communication among experts.
What has not changed is the recommendation to limit antibiotic prophylaxis to patients at high risk of IE having dental procedures, and the guidelines provide detailed information on antibiotic treatment for every type of organism and situation.
Access all ESC Clinical Practice Guidelines here
About the European Society of CardiologyThe European Society of Cardiology (ESC) represents more than 90 000 cardiology professionals across Europe and worldwide. Its mission is to reduce the burden of cardiovascular disease in Europe. About ESC Congress 2015ESC Congress is the world’s largest and most influential cardiovascular event contributing to global awareness of the latest clinical trials and breakthrough discoveries. ESC Congress 2015 takes place 29 August to 2 September at ExCel London in London, UK. Access the scientific programme. To access all the scientific resources from the sessions during the congress, visit ESC Congress 365.
© 2017 European Society of Cardiology. All rights reserved